Cancer Marker Profile (Pancreatic) Monoclonal Antibody Blood
What is this test?
Cancer marker profile (Pancreatic) Monoclonal Antibody Blood is used to detect whether an individual is having pancreatic cancer or not.
What is Pancreatic cancer?
Pancreatic cancer is a type of cancer that begins in the tissues of the pancreas. Pancreas present in the lower part of the stomach. It releases the enzymes that help in digestion of the food and hormones that manage the blood sugar levels. Pancreatic cancer spreads easily and fastly to the other organs.
What is CA19-9?
Carbohydrate antigen 19-9 CA 19-9 is a type of antigen released by the pancreatic cancer cells. It can be used as a tumor marker.
Why this test is performed?
This test is performed to find whether an individual is having pancreatic cancer or not. Your doctor may ask to perform this test if you experience any signs and symptoms such as abdominal pain, back pain, nausea, loss of appetite, jaundice, unexplained weight loss, increased blood sugar levels, vomiting etc.
This test is recommended by the physician to check the effectiveness of the treatment of pancreatic cancer. This also helps the physician to plan the treatment for an individual who is having pancreatic cancer.
Also known as Cancer marker profile (Pancreatic).
Test Preparation
Inform your doctor if you are on any medications, have any allergies or underlying medical conditions before your Cancer Marker Profile (Pancreatic) Monoclonal Antibody Blood. Your doctor will give specific instructions depending on your condition on how to prepare for Cancer Marker Profile (Pancreatic) Monoclonal Antibody Blood.
No specific preparation is required for this test. However, follow all the instructions given by the healthcare provider.
Understanding your test results
The normal reference range may vary depending on gender, age, health history, etc.
If your test results show high levels of CA 19-9 than the given normal reference range, it may indicate that the person is most likely to have pancreatic cancer and also indicates that the treatment is not working well.
If your test results are lower or in the normal range, it may indicate that the person is unlikely to have pancreatic cancer or may indicate that the treatment is working well.
Based on the test results, your doctor may advise appropriate medical treatments, lifestyle modifications, or further diagnostic tests.
| Gender | Age groups | Value |
| UNISEX | All age groups | 0-37 U/ml |